According to a report by Reuters, Walgreens will be supplying Kaleo’s Auvi-Q epinephrine injection in its pharmacies. The move comes during an ongoing EpiPen shortage.

There has been an acute shortage of Mylan’s EpiPen, which dominates the allergy market, with the health regulator last month extending the expiration date of specific lots of the treatment.

Privately held Kaleo’s Auvi-Q, used as emergency treatment for allergy bouts caused by food items such as peanuts, eggs, and milk, will be available in Walgreens stores across the nation, the company said.